文献速递生殖医学

确定提供与150 IU/日促卵泡素α相当卵巢反应的促卵泡素δ剂量

Establishing the follitropin delta dose that provides a comparable ovarian response to 150 IU/day follitropin alfa.
PubMed 文献 · Reprod Biomed Online · 2020-07-15

该研究为对两项随机对照试验中1591例IVF/ICSI患者的卵巢反应进行事后分析,旨在确定与150 IU/日促卵泡素α卵巢反应相当的促卵泡素δ日剂量。结果显示,促卵泡素δ 10.0 µg和10.3 µg分别在与150 IU/日促卵泡素α相比时获得相同数量的卵母细胞。结论认为,每日10 µg促卵泡素δ可提供与150 IU/日促卵泡素α相似的卵巢反应。

要点

  • 在II期和III期试验所有患者中,促卵泡素δ 10.0 µg和10.3 µg分别与150 IU/日促卵泡素α获相同卵母细胞数。
  • 在抗苗勒管激素≥15 pmol/l且无剂量调整的患者中,促卵泡素δ 9.7 µg和9.3 µg分别与150 IU/日促卵泡素α获相同卵母细胞数。
  • III期试验中,促卵泡素δ日剂量9.5-10.4 µg范围一致估计对应150 IU/日促卵泡素α的血清雌二醇浓度和≥12 mm卵泡数。

核心结论

  • 每日10 µg促卵泡素δ在IVF/ICSI患者中提供与150 IU/日促卵泡素α相似的卵巢反应。

研究设计与样本

  • 研究为对两项近期随机、评估者盲法、对照试验中1591例接受促性腺激素释放激素拮抗剂方案卵巢刺激的IVF/ICSI患者卵巢反应的事后分析。
  • 两项试验为促卵泡素δ开发项目中的II期剂量反应试验(参考组为整个刺激期间固定每日150 IU促卵泡素α)和III期疗效试验(比较组为150 IU/日促卵泡素α作为起始剂量)。

主要发现

  • 在II期和III期试验所有患者中,促卵泡素δ日剂量10.0 µg(95%CI 7.9-12.8)和10.3 µg(95%CI 9.7-10.8)分别与150 IU/日促卵泡素α获得相同数量的卵母细胞。
  • 在卵巢储备正常或高(基于血清抗苗勒管激素≥15 pmol/l)且无剂量调整的患者中,150 IU/日促卵泡素α与促卵泡素δ日剂量9.7 µg(95%CI 7.5-12.4)和9.3 µg(95%CI 8.6-10.1)在两项试验中分别获得相同数量的卵母细胞。
  • 在III期试验中,跨分析人群一致估计促卵泡素δ日剂量9.5-10.4 µg范围对应150 IU/日促卵泡素α的血清雌二醇浓度和刺激结束时≥12 mm卵泡数。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

RESEARCH QUESTION: The objective of this investigation was to determine the daily follitropin delta dose (µg) providing a similar ovarian response to 150 IU/day follitropin alfa. DESIGN: The study was a post-hoc analysis of ovarian response in 1591 IVF/intracytoplasmic sperm injection (ICSI) patients undergoing ovarian stimulation in a gonadotrophin-releasing hormone antagonist protocol in two recent randomized, assessor-blind, controlled trials in the development programme for follitropin delta: a phase II dose-response trial with a reference arm of a fixed daily dose of 150 IU follitropin alfa throughout stimulation, and a phase III efficacy trial with a comparator arm of 150 IU/day follitropin alfa as a starting dose. RESULTS: Daily follitropin delta doses of 10.0 µg (95% confidence interval [CI] 7.9-12.8) and 10.3 µg (95% CI 9.7-10.8) yielded the same number of oocytes as 150 IU/day follitropin alfa for all patients participating in the phase II and III trials, respectively. When analysing patients with either normal or high ovarian reserve (based on serum anti-Mullerian hormone ≥15 pmol/l) and no dose changes, the same number of oocytes was obtained with 150 IU/day follitropin alfa and daily doses of follitropin delta of 9.7 µg (95% CI 7.5-12.4) and 9.3 µg (95% CI 8.6-10.1) in the two trials. Daily follitropin delta doses in the range 9.5-10.4 µg were consistently estimated to correspond to 150 IU/day follitropin alfa for serum oestradiol concentration and number of follicles ≥12 mm at the end of stimulation across analysis populations in the phase III trial. CONCLUSIONS: A daily follitropin delta dose of 10 µg provides a similar ovarian response to 150 IU/day follitropin alfa in IVF/ICSI patients.

来源:Reprod Biomed Online,查看原文。版权归原作者所有。

引用

  1. Arce JC, Larsson P, García-Velasco JA, et al. Establishing the follitropin delta dose that provides a comparable ovarian response to 150 IU/day follitropin alfa. Reprod Biomed Online. 2020. PMID: 32819842. doi:10.1016/j.rbmo.2020.07.006

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。